Passamonti F.; Romano A.; Salvini M.; Merli F.; Porta M.G.D.; Bruna R.; Coviello E.; Romano I.; Cairoli R.; Lemoli R.; Farina F.; Venditti A.; Busca A.; Ladetto M.; Massaia M.; Pinto A.; Arcaini L.; Tafuri A.; Marchesi F.; Fracchiolla N.; Bocchia M.; Armiento D.; Candoni A.; Krampera M.; Luppi M.; Cardinali V.; Galimberti S.; Cattaneo C.; La Barbera E.O.; Mina R.; Lanza F.; Visani G.; Musto P.; Petrucci L.; Zaja F.; Grossi P.A.; Bertu L.; Pagano L.; Corradini P.; Derenzini E.; Marchetti M.; Scattolin A.M.; Corso A.; Tosi P.; Gherlinzoni F.; Passerini C.G.; Cavo M.; Fava C.; Turrini M.; Visco C.; Zappasodi P.; Merli M.; Mora B.; Vannucchi A.M., COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies, «BRITISH JOURNAL OF HAEMATOLOGY», 2021, 195, pp. 371 - 377 [Scientific article]Open Access
Ludwig H.; Sonneveld P.; Facon T.; San-Miguel J.; Avet-Loiseau H.; Mohty M.; Mateos M.-V.; Moreau P.; Cavo M.; Pawlyn C.; Zweegman S.; Engelhardt M.; Driessen C.; Cook G.; Dimopoulos M.A.; Gay F.; Einsele H.; Delforge M.; Caers J.; Weisel K.; Jackson G.; Garderet L.; van de Donk N.; Leleu X.; Goldschmidt H.; Beksac M.; Nijhof I.; Schreder M.; Abildgaard N.; Hajek R.; Zojer N.; Kastritis E.; Broijl A.; Schjesvold F.; Boccadoro M.; Terpos E., COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network, «THE LANCET. HAEMATOLOGY», 2021, 8, pp. e934 - e946 [Scientific article]
Mateos M.-V.; Dimopoulos M.A.; Cavo M.; Suzuki K.; Knop S.; Doyen C.; Lucio P.; Nagy Z.; Pour L.; Grosicki S.; Crepaldi A.; Liberati A.M.; Campbell P.; Yoon S.-S.; Iosava G.; Fujisaki T.; Garg M.; Iida S.; Blade J.; Ukropec J.; Pei H.; Van Rampelbergh R.; Kudva A.; Qi M.; San-Miguel J., Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2021, 21, pp. 785 - 798 [Scientific article]Open Access
Dimopoulos, MA; Terpos, E; Boccadoro, M; Delimpasi, S; Beksac, M; Katodritou, E; Moreau, P; Baldini, L; Symeonidis, A; Bila, J; Oriol, A; Mateos, MV; Einsele, H; Orfanidis, I; Ahmadi, T; Ukropec, J; Kampfenkel, T; Schecter, JM; Qiu, YP; Amin, H; Vermeulen, J; Carson, R; Sonneveld, P, Adrian Alegre Amor, Luca Baldini, Meral Beksac, Angelo Belotti, Lotfi Benboubker, Britta Besemer, Sevgi Besisik, Jelena Bila, Mario Boccadoro, Michele Cavo, Javier De La Rubia Comos, Sosana Delimpasi, Meletios A Dimopoulos, Chantal Doyen, Dominik Dytfeld, Monika Engelhardt, Thierry Facon, Roberto Foà, Hartmut Goldschmidt, Sebastian Grosicki, Roman Hajek, Guner Hayri Ozsan, Cyrille Hulin, Brian Iversen, Lionel Karlin, Eirini Katodritou, Stefan Knop, Marie-Christine Kyrtsonis, Juan Jose Lahuerta, Xavier Leleu, Carmen Martinez Chamorro, María-Victoria Mateos Manteca, Nathalie Meuleman, Monique Minnema, Philippe Moreau, Massino Offidani, Albert Oriol Rocafiguera, Mustafa Pehlivan, Ludek Pour, Henk Th J Roe, Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial, «THE LANCET ONCOLOGY», 2021, 22, pp. 801 - 812 [Scientific article]
Kastritis E.; Palladini G.; Minnema M.C.; Wechalekar A.D.; Jaccard A.; Lee H.C.; Sanchorawala V.; Gibbs S.; Mollee P.; Venner C.P.; Lu J.; Schonland S.; Gatt M.E.; Suzuki K.; Kim K.; Cibeira M.T.; Beksac M.; Libby E.; Valent J.; Hungria V.; Wong S.W.; Rosenzweig M.; Bumma N.; Huart A.; Dimopoulos M.A.; Bhutani D.; Waxman A.J.; Goodman S.A.; Zonder J.A.; Lam S.; Song K.; Hansen T.; Manier S.; Roeloffzen W.; Jamroziak K.; Kwok F.; Shimazaki C.; Kim J.-S.; Crusoe E.; Ahmadi T.; Tran N.; Qin X.; Vasey S.Y.; Tromp B.; Schecter J.M.; Weiss B.M.; Zhuang S.H.; Vermeulen J.; Merlini G.; Comenzo R.L., Bradley Augustson, Fiona Kwok, Peter Mollee, Simon Gibbs, Chantal Doyen, Greet Bries, Isabelle Vande Broek, Ka Lung Wu, Koen Theunissen, Koen Van Eygen, Michel Delforge, Nathalie Meuleman, Philip Vlummens, Angelo Maiolino, Breno Moreno de Gusmão, Carlos Eduardo Miguel, Edvan Crusoe, Fernanda Moura, Fernanda Seguro, Jandey Bigonha, Juliane Musacchio, Karla Zanella, Laura Garcia, Marcelo Eduardo Z, Daratumumab-based treatment for immunoglobulin light-chain amyloidosis, «THE NEW ENGLAND JOURNAL OF MEDICINE», 2021, 385, Article number: https://www.nejm.org/doi/10.1056/NEJMoa2028631? , pp. 46 - 58 [Scientific article]Open Access
Forte D.; Barone M.; Morsiani C.; Simonetti G.; Fabbri F.; Bruno S.; Bandini E.; Sollazzo D.; Collura S.; Deregibus M.C.; Auteri G.; Ottaviani E.; Vianelli N.; Camussi G.; Franceschi C.; Capri M.; Palandri F.; Cavo M.; Catani L., Distinct profile of CD34+ cells and plasma-derived extracellular vesicles from triple-negative patients with Myelofibrosis reveals potential markers of aggressive disease, «JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH», 2021, 40, Article number: 49 , pp. 49 - 49 [Scientific article]Open Access
Stanzani M.; Sassi C.; Lewis R.; Sartor C.; Rasetto G.; Cavo M.; Battista G., Early low-dose computed tomography with pulmonary angiography to improve the early diagnosis of invasive mould disease in patients with haematological malignancies: A pilot study, «JOURNAL OF INFECTION», 2021, 83, pp. 371 - 380 [Scientific article]
Auner H.W.; Gavriatopoulou M.; Delimpasi S.; Simonova M.; Spicka I.; Pour L.; Dimopoulos M.A.; Kriachok I.; Pylypenko H.; Leleu X.; Doronin V.; Usenko G.; Hajek R.; Benjamin R.; Dolai T.K.; Sinha D.K.; Venner C.P.; Garg M.; Stevens D.A.; Quach H.; Jagannath S.; Moreau P.; Levy M.; Badros A.; Anderson L.D.; Bahlis N.J.; Facon T.; Mateos M.V.; Cavo M.; Chai Y.; Arazy M.; Shah J.; Shacham S.; Kauffman M.G.; Richardson P.G.; Grosicki S., Effect of age and frailty on the efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma, «AMERICAN JOURNAL OF HEMATOLOGY», 2021, 96, pp. 708 - 718 [Scientific article]Open Access
Mateos, M. V.; Gavriatopoulou, M.; Facon, T.; Auner, H. W.; Leleu, X.; Hajek, R.; Dimopoulos, M. A.; Delimpasi, S.; Simonova, M.; Spicka, I.; Pour, L.; Kriachok, I.; Pylypenko, H.; Doronin, V.; Usenko, G.; Benjamin, R.; Dolai, T. K.; Sinha, D. K.; Venner, C. P.; Garg, M.; Stevens, D. A.; Quach, H.; Jagannath, S.; Moreau, P.; Levy, M.; Badros, A. Z.; Anderson, L. D.; Bahlis, N. J.; Cavo, M.; Chai, Y.; Jeha, J.; Arazy, M.; Shah, J.; Shacham, S.; Kauffman, M. G.; Richardson, P. G.; Grosicki, S., Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma, «JOURNAL OF HEMATOLOGY & ONCOLOGY», 2021, 14, Article number: 59 , pp. 1 - 5 [Scientific article]Open Access
Gentile M.; Specchia G.; Derudas D.; Galli M.; Botta C.; Rocco S.; Conticello C.; Califano C.; Giuliani N.; Mangiacavalli S.; Attingenti E.; Lombardo A.; Brunori M.; Rossi E.; Antonioli E.; Ria R.; Zambello R.; Di Renzo N.; Mele G.; Marcacci G.; Musto P.; Capalbo S.; Cascavilla N.; Cerchione C.; Belotti A.; Criscuolo C.; Uccello G.; Curci P.; Vigna E.; Fraticelli V.; Vincelli D.; Bonalumi A.; Siniscalchi A.; Stocchi R.; Martino M.; Ballanti S.; Gangemi D.; Gagliardi A.; Gamberi B.; Pompa A.; Recchia A.G.; Tripepi G.; Pitino A.; Frigeri F.; Consoli U.; Bringhen S.; Zamagni E.; Patriarca F.; De Stefano V.; Di Raimondo F.; Palmieri S.; Petrucci M.T.; Offidani M.; Boccadoro M.; Cavo M.; Morabito F., Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials, «HAEMATOLOGICA», 2021, 106, pp. 291 - 294 [Scientific article]Open Access
Tacchetti P.; Rocchi S.; Barbato S.; Zamagni E.; Pantani L.; Mancuso K.; Rizzello I.; Cavo M., Emerging and current treatment combinations for transplant-ineligible multiple myeloma patients, «EXPERT REVIEW OF HEMATOLOGY», 2021, 14, pp. 1085 - 1098 [Scientific article]
Ciciarello M.; Corradi G.; Forte D.; Cavo M.; Curti A., Emerging bone marrow microenvironment‐driven mechanisms of drug resistance in acute myeloid leukemia: Tangle or chance?, «CANCERS», 2021, 13, Article number: 5319 , pp. 5319 - 5319 [Scientific article]Open Access
Chari A.; Munder M.; Weisel K.; Jenner M.; Bygrave C.; Petrucci M.T.; Boccadoro M.; Cavo M.; van de Donk N.W.C.J.; Turgut M.; Demirkan F.; Karadogan I.; Libby E.; Kleiman R.; Kuppens S.; Bandekar R.; Neff T.; Heuck C.; Qi M.; Clemens P.L.; Goldschmidt H., Evaluation of Cardiac Repolarization in the Randomized Phase 2 Study of Intermediate- or High-Risk Smoldering Multiple Myeloma Patients Treated with Daratumumab Monotherapy, «ADVANCES IN THERAPY», 2021, 38, pp. 1328 - 1341 [Scientific article]
Cavo M.; Tacchetti P.; Zamagni E., Expanding CD38-targeting triplets for relapsed or refractory multiple myeloma, «THE LANCET», 2021, 397, pp. 2311 - 2313 [Scientific article]
Rosinol L.; Beksac M.; Zamagni E.; Van de Donk N.W.C.J.; Anderson K.C.; Badros A.; Caers J.; Cavo M.; Dimopoulos M.-A.; Dispenzieri A.; Einsele H.; Engelhardt M.; Fernandez de Larrea C.; Gahrton G.; Gay F.; Hajek R.; Hungria V.; Jurczyszyn A.; Kroger N.; Kyle R.A.; Leal da Costa F.; Leleu X.; Lentzsch S.; Mateos M.V.; Merlini G.; Mohty M.; Moreau P.; Rasche L.; Reece D.; Sezer O.; Sonneveld P.; Usmani S.Z.; Vanderkerken K.; Vesole D.H.; Waage A.; Zweegman S.; Richardson P.G.; Blade J., Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations, «BRITISH JOURNAL OF HAEMATOLOGY», 2021, 194, pp. 496 - 507 [Scientific article]
